Does NILUTAMIDE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with NILUTAMIDE (Nilutamide). This represents 9.7% of all adverse event reports for NILUTAMIDE.
6
Reports of Malignant neoplasm progression with NILUTAMIDE
9.7%
of all NILUTAMIDE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NILUTAMIDE?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILUTAMIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does NILUTAMIDE Cause?
Prostatic specific antigen increased (16)
Asthenia (10)
Dyspnoea (9)
Apathy (7)
Arthralgia (7)
Burning sensation (7)
Diverticulitis (7)
Dizziness (7)
Fatigue (7)
Flatulence (7)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)